Inhibition of platelet-derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor α positive breast cancer

समान संसाधन

• Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
  द्वारा: You, Daeun, और अन्य
  प्रकाशित: (2017)
• Benefit of tamoxifen in estrogen receptor positive DCIS of the breast
  द्वारा: Fausto, Petrelli, और अन्य
  प्रकाशित: (2012)
• Celastrol attenuates the inflammatory response by inhibiting IL-1β expression in triple-negative breast cancer cells
  द्वारा: You, Daeun, और अन्य
  प्रकाशित: (2021)
• Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
  द्वारा: Han, Wonshik, और अन्य
  प्रकाशित: (2006)
• Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines
  द्वारा: Kim, Yun Gyoung, और अन्य
  प्रकाशित: (2019)